Vistagen Therapeutics (VTGN) traded down -5.56 % during a 24 hours period ending at 03:14 AM Central Europe on Wednesday 28th. One Vistagen Therapeutics stock can currently be bought for about USD 0.17 on popular exchanges. Current supply of Vistagen Therapeutics stocks is 44.4 mn. Vistagen Therapeutics has a current market capitalization of USD 7.9 mn and approximately USD 130.1 k worth of Vistagen Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Vistagen Therapeutics has traded -43.33 % down. Simple moving average of last 200 days is at USD 0.46. The highest price of past 52 weeks was recorded at USD 5.14 on 11/24/2025. 52 weeks low was at USD 0.17 on 10/26/2026.
Here is how related stocks have performed in the past 24 hours:
Bridgeline Digital (BLIN) traded down -1.39 % and now trades at USD 0.72. Current market capitalisation for Bridgeline Digital is USD 9.3 mn.
Bullfrog Ai (BFRG) traded down -2.63 % and now trades at USD 0.48. Current market capitalisation for Bullfrog Ai is USD 9.2 mn.
Willamette Valley Vineyards (WVVI) traded up 0.53 % and now trades at USD 1.87. Willamette Valley Vineyards has a market capitalisation of USD 9.4 mn.
Sadot (SDOT) traded up 0.86 % and now trades at USD 7.29. Current market capitalisation for Sadot is USD 9.4 mn.
Metavia (MTVA) traded down -11.96 % and now trades at USD 1.15. Current market capitalisation for Metavia is USD 9.1 mn.
About Vistagen Therapeutics
Vistagen Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, United States. The company specializes in developing medications for patients with central nervous system-related diseases and disorders. Vistagen Therapeutics serves patients and healthcare professionals globally, and its website can be accessed under www.vistagen.com . The company’s stock is traded on the Nasdaq stock exchange.